References
- Bowman J. Historical overview: hemolytic disease of the newborn. In: Kennedy MS, Wilson SM, Kelton JG, eds. Perinatal transfusion medicine. Arlington, VA: American Association of Blood Banks, 1990:1-52.
- James LS. Shock in the newborn in relation to hydrops. Ann ObstetGynecol 1971;92:599-601.
- Walker RH, ed. Technical manual. 10th ed. Arlington, VA: American Association of Blood Banks, 1990:377-410.
- Cohen F, Zuelzer WW. Mechanisms of isoimmunization. II. Transplacental passage and postnatal survival of fetal erythrocytes in heterospecific pregnancies. Blood 1967; 30:796-804.
- Lloyd LK, Miya F, Hebertson RM, et al. Intrapartum fetal bleeding in Rh negative women. ObstetGynecol 1990; 56:285-8.
- Kleihauer E, Braun H, Betke K. Demonstration von fetalem hämoglobin in den erythrozyteneinesblutauastrichs. KlinWochenschr 1957;35:637-8.
- Bowman JM, Pollack JM, Pension LE. Fetomatemaltranspla-cental hemorrhage during pregnancy and after delivery. Vox Sang 1986;51:117-21.
- Warren RC, Butler J, Morsman JM, et al. Does chorionic villus sampling cause FMH? Lancet 1985;1:691.
- Levine P. The influence of the ABO system on Rh hemolytic disease. Hum Biol 1958;30:14–28.
- Race RR, Sanger R. Blood groups in man. Oxford: Scientific Publications, 1950.
- Stern K, Goodman HS, Berger M. Experimental isoimmunization to hemoantigens in man. J Immunol 1961; 87:189-98.
- Woodrow JC, Donohue WTA. Rh immunization by pregnancy: results of a survey and their relevance to prophylactic therapy. BrMedJ 1968;4:139-44.
- Bowman JM. Rh erythroblastosisfetalis. SeminHematol 1975; 12:189-207.
- Ascari WQ, Levine P, Pollack W. Incidence of maternal Rh immunization by ABO compatible and incompatible pregnancies. Br Med J 1969;1:399-401.
- Freda VJ, Gorman JG, Pollack W. Successful prevention of experimental Rh sensitization in man with an anti-Rh gamma 2-globulin antibody preparation: a preliminary report. Transfusion 1964;4:26-32.
- Zipursky A, Israels LG. The pathogenesis and prevention of Rh immunization. Can Med Assoc J 1967;97:1245-57.
- Combined Study. Prevention of Rh-haemolytic disease. Br MedJ 1966;2:901-14.
- Clarke CA, Donohoe WTA, McConnell RB, et al. Further experimental studies in the prevention of Rh-haemolytic disease. Br Med J 1963;1:979-84.
- Chown B, Duff AM, James J, et al. Prevention of primary Rh immunization: first report of the Western Canadian trial, 1966-1968. Can Med Assoc J 1969;100:1021-4.
- Bowman JM, Chown B, Lewis M, et al. Rh-isoimmunization during pregnancy: antenatal prophylaxis. Can Med Assoc J 1978;118:623-7.
- Wenk RE, Goldstein P, Felix JK. Alloimmunization by hr’(c), hemolytic disease of newborns, and perinatal management.ObstetGynecol 1986;67:623-6.
- Powell PJ, Brown SE, Dike AE, Inskip MJ. The significance of anti-c alloimmunization in pregnancy. Br J Obstet Gynecol 1986;93:1044-8.
- Farr V, Gray E. Pregnancy outcome in mothers who develop Kell antibodies. Scot Med J 1988;33:300-3.
- Biermé SJ, Blane M, Abbal M, et al. Oral Rh treatment for severely immunized mothers. Lancet 1979;1:604–5.
- Barnes RMR, Duguid JKM, Roberts FM, et al. Oral administration of erythrocyte membrane antigen does not suppress anti-Rh(D) antibody responses in humans. Clin Exp Immunol 1987;67:220-6.
- Carter BB. Preliminary report on a substance which inhibits anti-Rh serum. Am J ClinPathol 1947;17:646-9.
- Gusdon JP, Caudle MR, Herbst GA, Iannuzzi NP. Phagocytosis and erythroblastosis: I. Modification of the neonatal response by promethazine hydrochloride. Am J ObstetGynecol 1976;125:224-6.
- Bowman JM, Pollock JM. Reversal of Rh alloimmunization. Fact or fancy? Vox Sang 1984;47:209-15.
- De Silva M, Contreras M, Mollison PL. Failure of passively administered anti-Rh to prevent secondary Rh immune responses. Vox Sang 1985;48:178-80.
- Graham-Pole J, Barr W, Willoughby MLN. Continuous flow plasmapheresis in management of severe Rhesus disease. Br MedJ 1977;1:1185-8.
- Robinson EAE, Tovey LAD. Intensive plasma exchange in the management of severe Rh disease. Br J Haematol 1980;45:621-31.
- Berlin G, Selbing A, Ryden G. Rhesus haemolytic disease treated with high-dose intravenous immunoglobulin (letter). Lancet 1985;1:1153.
- de la Camara C, Arrieta R, Gonzalez A, et al. High-dose intravenous immunoglobulin as the sole prenatal treatment for severe Rh immunization. N Engl J Med 1988;318:519-20.
- Tabb PA, Inglis J, Savage DCL, Walker CHM. Controlled trial of phototherapy of limited duration in the treatment of physiological hyperbilirubinemia in low-birth-weight infants. Lancet 1972;2:1211.
- Hill RM, Meza GC. Utilization of blood components in neonatal medicine. In: Bell CA, ed. A seminar on perinatal blood banking. Washington, DC: American Association of Blood Banks, 1978:109-30.
- Judd WJ, Luban NLC, Ness PM, et al. Prenatal and perinatal immunohematology: recommendations for serologic management of the fetus, newborn infant, and obstetric patient. Transfusion 1990;30:175-83.
- Widmann FK, ed. Standards for blood banks and transfusion services. 14th ed. Arlington, VA: American Association of Blood Banks, 1991.
- Pollack W, Ascari WQ, Kockesky RJ, et al. Studies on Rh prophylaxis: I. Relationship between doses of anti-Rh and size of antigenic stimulus. Transfusion 1971;11:333-9.
- Rivat L, Parent M, Rivat C. Accident survenuaprés injection de gamma-globulines anti-Rh du à la présence d’anticorps anti-IgA (letter). Press Med 1970;78:2072.
- Bowman JM, Friesen AD, Pollock JM, et al. WinRho: Rh immune globulin prepared by ion exchange for intravenous use. Can Med Assoc J 1980;123:1121-5.
- Crawford DH, Barlow MJ, Harrison JF, et al. Production of human monoclonal antibody to rhesus D antigen. Lancet 1983;1:386-8.
- Bron D, Feinberg MB, Teng NNH, et al. Production of human monoclonalIgG antibodies against rhesus (D) antigen. Proc Natl Acad Sci (USA) 1984;81:3214-7.
- Kennedy MS, Wilson SM, Kelton JG, eds. Perinatal transfusion medicine. Arlington, VA: American Association of Blood Banks, 1990.